DanielBoiarskyMD

Internal Medicine • New Haven, CT

Physician

Join to view full profile

Dr. Boiarsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Boiarsky's full profile

Already have an account?

Office
20 York St
New Haven, CT 06510
Phone+1 203-688-4242

Education & Training

Albert Einstein College of MedicineClass of 2020

Certifications & Licensure

CT State Medical License 2024 - 2027
MA State Medical License 2020 - 2026
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancer.
Daniel Boiarsky, Alok K Tewari, Doga C Gulhan, Ziad Bakouny, Guruprasad Ananda
The Prostate. 2024-12-01
2 citations
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer.
Daniel Boiarsky, Doga C Gulhan, Hunter Savignano, Gitanjali Lakshminarayanan, Heather M McClure
Clinical Genitourinary Cancer. 2024-04-01
6 citations
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
Jacob E Berchuck, Daniel Boiarsky, Rebecca Silver, Rajitha Sunkara, Heather M McClure
JCO Precision Oncology. 2022-08-01